AndrewPoklepovicMD

Clinical Trials

• Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma Start of enrollment: 2004 Sep 01

  Completed

  Phase 1

• Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Dec 13

  Completed

  Phase 2

• Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Start of enrollment: 2009 Oct 28

  Completed

  Phase 3

• Sorafenib and Vorinostat in Treating Patients With Advanced Liver Cancer Start of enrollment: 2010 Aug 10

  Completed

  Phase 1

• Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery Start of enrollment: 2011 May 25

  Active, not recruiting

  Phase 3

• Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer Start of enrollment: 2011 Mar 14

  Completed

  Phase 1

• Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers Start of enrollment: 2011 Aug 11

  Completed

  Phase 1

• Randomized RT +/- Lapatinib for Advanced Solid Tumor Cancer Patients Receiving Radiation Therapy for Metastatic Disease Start of enrollment: 2011 Sep 01

  Terminated

  Early Phase 1

• A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma Start of enrollment: 2011 Sep 01

  Completed

  Phase 3

• Pemetrexed Disodium and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors Start of enrollment: 2011 Oct 01

  Completed

  Phase 1

• Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer Start of enrollment: 2013 Feb 01

  Completed

  Phase 2

• Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Metastatic Triple-Negative Breast Cancer Start of enrollment: 2013 Oct 02

  Completed

  Phase 2

• A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab Start of enrollment: 2014 May 05

  Completed

  Phase 1

• 2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer Start of enrollment: 2016 Jan 28

  Terminated

  Phase 2

• Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer Start of enrollment: 2016 Jul 08

  Terminated

  Phase 1

• Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca Start of enrollment: 2019 May 01

  Recruiting

  Phase 1, Phase 2

• Join now to see all